Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2017
Mar. 31, 2016
Current assets:    
Cash and cash equivalents $ 78.9 $ 107.1
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 108.9 17.0
Accounts and other receivables, net of provision for doubtful trade debts of US$0.9 million and US$1.1 million as of 31 March 2017 and 31 March 2016 199.5 173.3
Inventories 202.9 193.0
Prepaid expenses and other current assets 28.3 18.1
Insurance receivable - Asbestos 5.7 16.7
Workers' compensation - Asbestos 2.9 4.1
Total current assets 632.1 534.3
Property, plant and equipment, net 879.0 867.0
Insurance receivable - Asbestos 58.1 149.0
Workers' compensation - Asbestos 40.4 46.8
Deferred income taxes 26.9 25.9
Deferred income taxes - Asbestos 356.6 384.9
Other assets 19.6 21.5
Total assets 2,012.7 2,029.4
Current liabilities:    
Accounts payable and accrued liabilities 173.5 127.2
Short-term debt - Asbestos 52.4 50.7
Accrued payroll and employee benefits 60.5 63.0
Accrued product warranties 9.4 12.2
Income taxes payable 1.9 4.8
Asbestos liability 116.4 125.9
Workers' compensation - Asbestos 2.9 4.1
Other liabilities 11.8 11.9
Total current liabilities 428.8 399.8
Long-term debt 564.5 501.8
Deferred income taxes 94.8 82.1
Accrued product warranties 37.2 33.1
Asbestos liability 1,043.3 1,176.3
Workers' compensation - Asbestos 40.4 46.8
Other liabilities 15.9 14.7
Total liabilities 2,224.9 2,254.6
Commitments and contingencies (Note 13)
Shareholders' deficit:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 440,843,275 shares issued and outstanding at 31 March 2017 and 445,579,351 shares issued and outstanding at 31 March 2016 229.1 231.4
Additional paid-in capital 173.8 164.4
Accumulated deficit (612.9) (621.8)
Accumulated other comprehensive (loss) income (2.2) 0.8
Total shareholders' deficit (212.2) (225.2)
Total liabilities and shareholders' deficit $ 2,012.7 $ 2,029.4